NCT06708091View on ClinicalTrials.gov

Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-transporter 2 Inhibitor to Gliclazide Modified Release

CompletedOBSERVATIONAL

Enrollment

537

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions

Type 2 Diabetes

Trial Locations (1)

92284

Servier Affaires Médicales, Suresnes

All Listed Sponsors

lead

Servier Affaires Médicales

INDUSTRY